bibliographic entry 2515008 [be/2515008]
https://w3id.org/oc/corpus/be/2515008

is a
content
  • US Food and Drug Administration. FDA Briefing Document. NDA 202293. Dapagliflozin oral tablets, 5 and 10 MG, Silver Spring; Food and Drug Administration, 2013. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM378076.pdf. (accessed Aug 30, 2016)
references